Latest Breaking News On - Avidity partners - Page 4 : comparemela.com

EQS-News: Immunic, Inc Reports Year End 2023 Financial Results and Provides Corporate Update

EQS-News: Immunic, Inc Reports Year End 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittJessica breuPaula schwartzEdna kaplanImmunic incAssembly conferenceRx communications groupExchange commissionDevelopment rd expensesAssociation of european coeliac societiesProgram in relapsing multiple sclerosis ongoingTrademark officeDistribution servicesAnnual resultsReports year end

I-Mab: Trading Below Net Cash With Multiple Upside Options (NASDAQ:IMAB)

I-Mab: Trading Below Net Cash With Multiple Upside Options (NASDAQ:IMAB)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Hong kongJohn hayslipZhongshan sinobioway hygeneRaj kannanTech industriesChina rd centerDrug administrationChina the hangzhou companyHangzhou companyNovo nordiskAbstract molecularForty sevenAvidity partnersOctagon capital advisorsLake bleu capitalChief executive officer

Jasper Therapeutics (JSPR) Announces Pricing of $50 Million Underwritten Offering of Common Stock

Jasper Therapeutics (JSPR) Announces Pricing of $50 Million Underwritten Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Great point partnersJasper therapeutics incJasper therapeuticsChronic inducible urticariaAvidity partnersBoxer capitalQiming venture partners united statesRock springs capitalSamsara biocapitalSoleus capitalVelan capitalWoodline capital

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock

REDWOOD CITY, Calif., Feb. 06, 2024 Jasper Therapeutics, Inc. , a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit to address diseases such.

New yorkUnited statesAlex grayLauren walkerJoyce allaireEvercore groupExchange commissionGreat point partnersGlobenewswire incJasper therapeutics incChronic inducible urticariaAvidity partnersPoint partnersVenture partners united statesSprings capitalSamsara biocapital

Dianthus Therapeutics Announces $230 Million Private Placement

NEW YORK and WALTHAM, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) Dianthus Therapeutics, Inc. (“Dianthus” or the “Company”) (NASDAQ: DNTH), a clini.

New yorkUnited statesRaymond jamesTellus bioventuresExchange commissionDianthus therapeutics incBain capital life sciencesGreat point partnersCompany quarterly report on formAvidity partnersVenrock healthcare capital partnersOctagon capitalJanus henderson investorsVestal point capitalLogos capitalCatalio capital management